Skip to main content
Livermore
Livermore
ZHEN

ARK Invest

Superinvestor

ARK Investment Management LLC

SEC CIK
0001697748
Manager
Cathie Wood
Style
Growth
Latest filing
Aug 14, 2026

URGN holding history

UroGen Pharma Ltd. in every 13F filed by ARK Invest, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

URGN overviewAll 13F holders of URGNFull Q2 2026 holdings

Shares (Q2 2026)
101,508
Value
$3.74M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of URGN by ARK Invest, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026101,508$3.74M<0.1%−14,037−12.1%ReducedHolders
Q1 2026115,545$2.08M<0.1%−5,939−4.9%ReducedHolders
Q4 2025121,484$2.85M<0.1%−5,236−4.1%ReducedHolders
Q3 2025126,720$2.53M<0.1%−39,374−23.7%ReducedHolders
Q2 2025166,094$2.28M<0.1%−19,696−10.6%ReducedHolders
Q1 2025185,790$2.05M<0.1%+45,642+32.6%AddedHolders
Q4 2024140,148$1.49M<0.1%+18,514+15.2%AddedHolders
Q3 2024121,634$1.54M<0.1%−30,147−19.9%ReducedHolders
Q2 2024151,781$2.55M<0.1%+5,452+3.7%AddedHolders
Q1 2024146,329$2.19M<0.1%−15,196−9.4%ReducedHolders
Q4 2023161,525$2.42M<0.1%−53,747−25.0%ReducedHolders
Q3 2023215,272$3.02M<0.1%+13,354+6.6%AddedHolders
Q2 2023201,918$2.09M<0.1%−68,828−25.4%ReducedHolders
Q1 2023270,746$2.50M<0.1%+73,808+37.5%AddedHolders
Q4 2022196,938$1.75M<0.1%−84,763−30.1%ReducedHolders
Q3 2022281,701$2.34M<0.1%−20,423−6.8%ReducedHolders
Q2 2022302,124$1.61M<0.1%−31,348−9.4%ReducedHolders
Q1 2022333,472$2.90M<0.1%+146,979+78.8%AddedHolders
Q4 2021186,493$1.77M<0.1%−57,672−23.6%ReducedHolders
Q3 2021244,165$4.11M<0.1%−72,083−22.8%ReducedHolders
Q2 2021316,248$4.83M<0.1%+24,378+8.4%AddedHolders
Q1 2021291,870$5.69M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.